Pfanstiehl is a distinguished supplier to the pharmaceutical industry, specialising in the isolation, purification, custom synthesis, and scale-up development of cGMP, high purity, and low endotoxin (HPLE) injectable formulation components, pharmaceutical intermediates, and active pharmaceutical ingredients. Founded in 1919 by Carl A. Pfanstiehl, the company has established itself as a trusted partner in the production of critical pharmaceutical components, ensuring high standards of quality and compliance throughout its operations.

Services include:
– Regulatory Services
– Containment
– APIs (Active Pharmaceutical Ingredients)
– Analytical Services
– Custom Synthesis
– Scale-Up Development

Pfanstiehl remains committed to delivering exceptional service and high-quality products to its clients in the pharmaceutical sector. For more information, please visit pfanstiehl.com.